Stock Information
Relmada Therapeutics Inc (RLMD)
Ticker Symbol: RLMD
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $368.16 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.96
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -47.52%
Latest News
-
Full Transcript: Relmada Therapeutics Q2 2026 Earnings Call
Mon, Oct 12, 2026 7:21 AM
-
Alpha Buying: 4 Biotech Stocks Insiders Are Betting On
Thu, Oct 8, 2026 11:32 AM
Key Financials
Financial data not available